Stock market Stats
Open in Telegram
Show more
📈 Analytical overview of Telegram channel Stock market Stats
Channel Stock market Stats (@stockinfo333) in the English language segment is an active participant. Currently, the community unites 18 958 subscribers, ranking 6 500 in the Economy & Finance category and 21 573 in the India region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 18 958 subscribers.
According to the latest data from 08 September, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 16 over the last 30 days and by 4 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 11.78%. Within the first 24 hours after publication, content typically collects 6.51% reactions from the total number of subscribers.
- Post reach: On average, each post receives 2 234 views. Within the first day, a publication typically gains 1 234 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 7.
- Thematic interests: Content is focused on key topics such as capacity, investor, lakh, tata, revenue.
📝 Description and content policy
Channel description not provided.
Thanks to the high frequency of updates (latest data received on 09 September, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Economy & Finance category.
18 958
Subscribers
+424 hours
+227 days
+1630 days
Data loading in progress...
Similar Channels
Tags Cloud
Incoming and Outgoing Mentions
---
---
---
---
---
---
Attracting Subscribers
September '26
September '26
+57
in 5 channels
August '26
+177
in 15 channels
Get PRO
July '26
+194
in 15 channels
Get PRO
June '26
+202
in 16 channels
Get PRO
May '26
+160
in 13 channels
Get PRO
April '26
+109
in 11 channels
Get PRO
March '26
+190
in 9 channels
Get PRO
February '26
+164
in 7 channels
Get PRO
January '26
+113
in 5 channels
Get PRO
December '25
+143
in 9 channels
Get PRO
November '25
+90
in 8 channels
Get PRO
October '25
+171
in 7 channels
Get PRO
September '25
+64
in 7 channels
Get PRO
August '25
+69
in 7 channels
Get PRO
July '25
+136
in 7 channels
Get PRO
June '25
+159
in 10 channels
Get PRO
May '25
+77
in 8 channels
Get PRO
April '25
+128
in 7 channels
Get PRO
March '25
+199
in 7 channels
Get PRO
February '25
+185
in 7 channels
Get PRO
January '25
+176
in 6 channels
Get PRO
December '24
+472
in 8 channels
Get PRO
November '24
+714
in 12 channels
Get PRO
October '24
+357
in 8 channels
Get PRO
September '24
+773
in 10 channels
Get PRO
August '24
+697
in 6 channels
Get PRO
July '24
+252
in 5 channels
Get PRO
June '24
+285
in 5 channels
Get PRO
May '24
+437
in 5 channels
Get PRO
April '24
+338
in 6 channels
Get PRO
March '24
+471
in 6 channels
Get PRO
February '24
+251
in 2 channels
Get PRO
January '24
+384
in 2 channels
Get PRO
December '23
+460
in 4 channels
Get PRO
November '23
+131
in 5 channels
Get PRO
October '23
+76
in 4 channels
Get PRO
September '23
+212
in 0 channels
Get PRO
August '23
+940
in 0 channels
Get PRO
July '23
+234
in 0 channels
Get PRO
June '23
+219
in 0 channels
Get PRO
May '23
+6
in 0 channels
Get PRO
April '23
+170
in 0 channels
Get PRO
March '23
+15
in 0 channels
Get PRO
February '23
+190
in 0 channels
Get PRO
January '23
+676
in 0 channels
Get PRO
December '220
in 0 channels
Get PRO
November '22
+115
in 0 channels
Get PRO
October '22
+446
in 0 channels
Get PRO
September '220
in 0 channels
Get PRO
August '220
in 0 channels
Get PRO
July '220
in 0 channels
Get PRO
June '220
in 0 channels
Get PRO
May '220
in 0 channels
Get PRO
April '220
in 0 channels
Get PRO
March '220
in 0 channels
Get PRO
February '220
in 0 channels
Get PRO
January '220
in 0 channels
Get PRO
December '210
in 0 channels
Get PRO
November '210
in 0 channels
Get PRO
October '210
in 0 channels
Get PRO
September '210
in 0 channels
Get PRO
August '210
in 0 channels
Get PRO
July '210
in 0 channels
Get PRO
June '210
in 0 channels
Get PRO
May '210
in 0 channels
Get PRO
April '210
in 0 channels
Get PRO
March '210
in 0 channels
Get PRO
February '210
in 0 channels
Get PRO
January '210
in 0 channels
Get PRO
December '20
+20 686
in 0 channels
| Date | Subscriber Growth | Mentions | Channels | |
| 09 September | +6 | |||
| 08 September | +6 | |||
| 07 September | +5 | |||
| 06 September | +6 | |||
| 05 September | +1 | |||
| 04 September | +10 | |||
| 03 September | +6 | |||
| 02 September | +13 | |||
| 01 September | +4 |
Channel Posts
| 2 |  Warning!
Some Global ETFs are going beserk in Indian markets.. These are some of them
Huge jump in daily traded prices and huge premium to underlying NAVs... | 3 653 |
| 3 | KSB LTD | MARINE & NUCLEAR GROWTH OPTIONALITY 🚢
Q2 / H1 FY26 PERFORMANCE
- Q2 Sales: ₹690.7 Cr | +3.6% YoY
- EBITDA: ₹86.7 Cr | -16% YoY
- PAT: ₹57.2 Cr | -18.8% YoY
- EPS: ₹3.29
- H1 Sales: ₹1,292 Cr vs ₹1,262 Cr | ~2.4% growth
- H1 PAT: ₹97 Cr vs ₹122 Cr | ~20% decline
- TTM Sales: ₹2,726 Cr | TTM PAT: ₹246 Cr
LONG-TERM TRACK RECORD
- FY15–FY25 Sales: ₹819 Cr → ₹2,696 Cr
- FY20–FY25 Sales: ₹1,208 Cr → ₹2,696 Cr
- 5Y Profit CAGR: ~25%
- 10Y Profit CAGR: ~16%
- ROE: ~18% | ROCE: ~25%
MARINE / SHIPBUILDING OPPORTUNITY ⚓️
- KSB is an approved Navy/Coast Guard supplier with access to government shipyards.
- Marine opportunity requires naval approvals, supply-chain development and gradual scaling.
- Management remains selective, rather than chasing every marine segment.
- Management indicated ₹100 Cr marine revenue next year would be a good outcome, equivalent to roughly 3–5% of turnover.
- Pumps are estimated at roughly 3–5% of total project value in large projects such as marine and data centres.
NUCLEAR + OTHER OPTIONALITY ☢️
- Nuclear localisation could create opportunities for import substitution.
- Additional growth avenues include:
- Shipbuilding / Marine
- Nuclear
- Industrial Capex
- Water
- Mining
- Data-centre Cooling
- Aftermarket / SupremeServ
ORDER BOOK & BALANCE SHEET
- Order book at June 2026: ₹2,744.5 Cr
- Net-cash balance sheet provides financial flexibility.
- High ROCE supports the industrial compounder thesis.
KEY CONCERNS ⚠️
- Current revenue growth remains only ~2–4%.
- Q2 PAT declined ~19% YoY.
- Margin pressure in the near term.
- Marine business is still small.
- Management is pursuing selective marine participation.
- Valuation remains elevated at around 55× earnings.
THE REAL KSB THESIS
- KSB is not a pure shipbuilding play.
- Core business remains the foundation, while Navy + shipbuilding + nuclear provide additional growth optionality.
- The key trigger is marine revenue scaling toward ₹100 Cr+, while nuclear and core industrial businesses continue compounding.
KEY TAKEAWAY
- KSB = Pumps + Valves + Nuclear + Marine + Aftermarket.
- The opportunity is a high-quality industrial compounder with emerging marine and nuclear optionality, but earnings growth and margin recovery need to justify the premium valuation. | 1 243 |
| 4 |  KSB LTD | 1 130 |
| 5 |  No text... | 651 |
| 6 |  Valuation comparison across New age companies Listed in India
source: Bloomberg, MOFSL | 2 846 |
| 7 |  Vinati Organics: with more & more Ibuprofen players getting backward integrated, IBB merchant market demand to decline. | 1 443 |
| 8 |  Just five stocks, HDFC Bank, ICICI Bank, Reliance, Bharti Airtel and L&T, account for ₹36.43 of every ₹100 invested in the Nifty 50. | 1 623 |
| 9 |  No text... | 1 396 |
| 10 | NSE के कुछ बड़े निवेशक
Few Big Names Holding NSE Sizeable Shares
1. Radhakishan Damani - 1.58%
2. Sunil Kant Munjal - 0.41%
3. S. Gopalakrishnan - 0.38%
4. Siddharth Balachandran - 0.27%
5. Vanaja Sundar Iyer - 0.18%
6. Siddharth Iyer - 0.15%
7. Lata Bhanshali - 0.15%
8. Bharat Taparia: 0.09%
9. Vipul Jayantilal Modi: 0.08%
10. Damani Estate And Finance: 0.07%
11. Dolly Khanna: 0.06% | 1 962 |
| 11 |  ROE vs ROCE 📊
ROE and ROCE are both important profitability ratios, but they measure different aspects of a business. | 2 016 |
| 12 |  No text... | 1 505 |
| 13 |  HBL ENGINEERING | MULTI-CAPEX TECHNOLOGY PLATFORM 🚢
BUSINESS & STRUCTURAL THEMES
- HBL is positioned across 7+ structural capex themes:
- 🚆 Railways: KAVACH, TMS, CTC & railway batteries.
- 🛡 Defence & Aerospace: Aircraft, missile, torpedo & submarine batteries.
- 🔋 Energy Storage: Li-ion, Ni-Cd & industrial batteries.
- ⚡️ E-Mobility: Motors, controllers, BMS & complete electric drivetrains.
- 🚢 Green Shipping: Marine batteries & electric propulsion.
- 🌊 Underwater Defence: Underwater electronics & sonar development.
- 🖥 Data Centres: High-reliability PLT batteries.
- 🌍 Exports: Global industrial & defence opportunities.
FY26 FINANCIAL PROFILE
- Revenue: ₹3,303 Cr
- PAT: ₹814 Cr
- Operating Margin: ~34%
- ROCE: ~58%
- ROE: ~45%
- Operating Cash Flow: ₹738 Cr
- Leverage: Very low
GREEN MARITIME | FROM TECHNOLOGY TO COMMERCIAL ORDER
- HBL has partnered with Cochin Shipyard in a 60:40 JV — Green Maritime Propulsion Pvt Ltd.
- JV has already placed an order on HBL for batteries for 2 electric tugs.
- Marine opportunity can potentially expand from:
Electric Tugs → Ferries → Inland Vessels → Hybrid/Electric Propulsion
- Key shift: Technology opportunity → Customer ecosystem → Initial commercial order.
UNDERWATER ELECTRONICS + DEFENCE
- HBL is pushing into underwater electronics, with potential commercialisation around FY28.
- Electronic-fuze programmes are progressing through qualification.
- Creates additional optionality beyond the existing battery business.
KAVACH | NEAR-TERM ENGINE
- KAVACH remains an important near-term growth/earnings opportunity.
- Railway modernisation provides multiple potential demand drivers across signalling, train management and railway battery systems.
THE BIGGER THESIS
- Existing cash-generating businesses can potentially fund the next generation of growth.
- Railways → Defence → Batteries → EVs → Green Marine → Underwater Electronics → Data Centres
- This creates multiple independent capex cycles supporting the same technology platform.
WHY HBL IS INTERESTING
- Not simply a battery company.
- High ROCE + strong cash generation + low leverage provide a strong base for investing into new businesses.
- The bigger opportunity may be the number of emerging businesses that can become meaningful revenue contributors over time.
KEY TAKEAWAY
- HBL sits at the intersection of Railway + Defence + Energy Storage + EV + Shipbuilding + Green Maritime + Data Centre capex themes.
- The key thing to track is not just today's revenue, but whether today's investments and qualifications convert into tomorrow's large revenue pools and sustained optionality. | 2 109 |
| 14 |  No text... | 1 784 |
| 15 |  Which battery chemistry will grow where?
Just look at the applications and how many verticals the battery industry has. Sodium-ion may be better suited for BESS, but batteries can be made using many different materials, including zinc-based chemistries.
First, we must understand the differences and performance ranges. Chemistry determines which battery will be lighter, more durable, safer, and capable of delivering a longer cycle life.
Battery chemistry and composition can change significantly every few years. Even China is now exploring different battery types, particularly sodium-ion, to reduce dependence on critical minerals, Africa-linked resources, and concentrated supply chains.
Therefore, One must have to study the entire battery-material supply chain. | 2 193 |
| 16 | Websites you can use for Investment Research:
1. Stock Screener - Company fundamentals
2. Cafemutual - MF industry updates
3. Value Research - MF analysis & ratings
4. Morningstar - Fund research Advanced
5. Advisorkhoj - MF data & tools
6. RupeeVest - MF analytics (Regular Plan)
7. PMS Bazaar - PMS research
8. Trendlyne - Stock screening & analysis
9. Equitymaster - Equity research Screener
10. IBEF - India industry data
11. IMF - Global macro data
12. TradingView - Charts & technicals
13. UnlistedZone - Unlisted stocks
14. AMFI India - Official MF data
15. StockEdge - Stock analysis
16. MF Central - MF portfolio & transactions
17. PMS AIF World - PMS/AIF data
18. Novel Investor - Valuation research
19. World PE Ratio - Global valuations
20. Macrotrends - 100 years Historical data
21. Economic Outlook - Economic research
22. India Macro Indicators - India macro data
23. Lazy Portfolio ETF - Global ETF research
24. MoSPI - Official statistics
25. PIB - Government updates
26. Fortune India 500 - Company rankings
27. ClearTax - Tax & finance
28. Zerodha Pulse - Market news
29. Trading Economics - Global economic data | 2 279 |
| 17 |  ROI | ROE | ROA | 2 301 |
| 18 | The numbers explain why peptides are attracting so much attention.
🔹One market estimate places the global peptide therapeutics market at $140.9 billion in 2025
🔹It is projected to reach $294.6 billion by 2033
🔹That implies an 8.7% CAGR
🔹Metabolic disorders accounted for the largest application share in this estimate
👉 The exact market size varies depending on methodology. But the direction is clear: peptides are becoming a significant pharma platform.
GLP-1 may be the catalyst, but it is unlikely to be the entire story.
🔹Semaglutide and tirzepatide demonstrated the commercial potential of peptide-based medicines
🔹The pipeline is expanding into dual agonists, multi-agonists and next-generation metabolic therapies
🔹In India, one estimate projects the GLP-1 market to grow from $240.5 million in 2026 to ~$1 billion by 2033
🔹India's anti-obesity drug market has also seen rapid growth alongside GLP-1 adoption
👉 The question is whether this demand creates a lasting manufacturing ecosystem.
The peptide value chain is far more layered than a conventional API story.
🔹Amino acids
🔹Protected amino acids & resins
🔹Peptide fragments
🔹Peptide synthesis
🔹Purification & isolation
🔹Peptide API
🔹Sterile fill-finish
🔹Cartridges, syringes & injection devices
👉 Not every company entering peptides will participate across this entire chain. And that difference could determine where the economics ultimately accrue.
The real competitive advantage may lie in the difficult steps, not simply in having "peptide capability."
🔹Long peptides require multiple sequential synthesis steps
🔹Small inefficiencies can compound as molecular complexity increases
🔹Purification requires separating the desired molecule from closely related impurities
🔹Commercial manufacturing also requires analytical, regulatory and scale-up expertise
👉 The industry is already facing capacity constraints across peptide APIs, sterile fill-finish, injector devices and glass cartridges.
Indian companies are entering the opportunity from very different points in the value chain.
🔹Divi's Laboratories → Building blocks, intermediates and peptide manufacturing integration
🔹Blue Jet Healthcare → Upstream peptide building blocks
🔹Neuland Laboratories → Complex peptide CDMO and commercial-scale synthesis
🔹Laurus Labs → Expanding peptide capabilities within a broader CDMO platform
🔹Sai Life Sciences → Discovery, development and peptide services
👉 The key is to differentiate between announced capability, development capacity and commercial-scale manufacturing.
Stock Fundamental in detail
@Fundamental3 | 2 188 |
| 19 |  Peptides may be evolving from a specialised drug category into a much broader pharmaceutical manufacturing opportunity.
🔹Applications span diabetes, obesity, oncology, endocrinology and rare diseases
🔹GLP-1 drugs have demonstrated that peptide medicines can address very large patient populations
🔹The next opportunity may lie not only in the drugs, but in the manufacturing ecosystem behind them
👉 A look at the peptide opportunity and India's positioning | 1 687 |
| 20 |  Interesting part here is that women's failure rate (who are only 17% of F&O traders) is consistently lower than men’s.
In FY26, 84.7% of women lost money vs 88.6% of men & even the average loss was slightly lower.
More trading activity + over confidence could be the main reasons most MEN need to think about in their strategies. | 1 622 |
